Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

"Efficacy of Once-weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05249881
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:33.183371+00:00
Published At
2022-08-05T00:00:00+00:00
Record Updated At
2022-08-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Diabetes Mellitus, Type 2", "Weight Change, Body"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-08-05"
protocolSection.identificationModule.nctId
"NCT05249881"
protocolSection.identificationModule.officialTitle
"\"Efficacy of Once-weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan.\""
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Diabetes Mellitus, Type 2 (protocolSection.conditionsModule.conditions)
  • Weight Change, Body (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.